NEUROPACE, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross
NEUROPACE, INC. (NPCE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross of 378.20 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Shareholders' Equity
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross · last filed 2026-08-11
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-06-30 was 378.20K shares, a 110.68% increase year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2026-03-31 was 0.00 shares, a 100.00% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-12-31 was 0.00 shares, a 100.00% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for the quarter ending 2025-09-30 was 11.95K shares, a 86.32% decline year-over-year.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2025 was 486.42K shares, a 4.75% decline from fiscal 2024.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2024 was 510.65K shares, a 26.55% decline from fiscal 2023.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2023 was 695.23K shares, a 0.73% increase from fiscal 2022.
- NEUROPACE, INC. share-based compensation arrangement by share-based payment award, options, grants in period, gross for fiscal 2022 was 690.22K shares, a 17.19% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross 12 month |
|---|---|---|---|---|
| 2026-06-30 | 378.20K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-11 | 378.20K shares 10-Q · filed 2026-08-11 | 378.20K shares derived: sum of 3 quarters · filed 2026-08-11 | 390.15K shares derived: sum of 4 quarters · filed 2026-08-11 |
| 2026-03-31 | 0.00 shares 10-Q · filed 2026-05-12 | 0.00 shares derived: sum of 2 quarters · filed 2026-05-12 | 11.95K shares derived: sum of 3 quarters · filed 2026-05-12 | 191.47K shares derived: sum of 4 quarters · filed 2026-05-12 |
| 2025-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-03 | 11.95K shares derived: sum of 2 quarters · filed 2026-03-03 | 191.47K shares derived: sum of 3 quarters · filed 2026-03-03 | 486.42K shares 10-K · filed 2026-03-03 |
| 2025-09-30 | 11.95K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | 191.47K shares derived: sum of 2 quarters · filed 2025-11-04 | 486.42K shares 10-Q · filed 2025-11-04 | 509.42K shares derived: sum of 4 quarters · filed 2025-11-04 |
| 2025-06-30 | 179.51K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-12 | 474.47K shares 10-Q · filed 2025-08-12 | 497.47K shares derived: sum of 3 quarters · filed 2025-08-12 | 584.84K shares derived: sum of 4 quarters · filed 2025-08-12 |
| 2025-03-31 | 294.96K shares 10-Q · filed 2025-05-13 | 317.96K shares derived: sum of 2 quarters · filed 2025-05-13 | 405.33K shares derived: sum of 3 quarters · filed 2025-05-13 | 517.44K shares derived: sum of 4 quarters · filed 2025-05-13 |
| 2024-12-31 | 23.00K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 110.37K shares derived: sum of 2 quarters · filed 2025-03-04 | 222.48K shares derived: sum of 3 quarters · filed 2025-03-04 | 510.65K shares 10-K · filed 2025-03-04 |
| 2024-09-30 | 87.37K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-12 | 199.48K shares derived: sum of 2 quarters · filed 2024-11-12 | 487.65K shares 10-Q · filed 2024-11-12 | 487.65K shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-06-30 | 112.11K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | 400.28K shares 10-Q · filed 2024-08-13 | 400.28K shares derived: sum of 3 quarters · filed 2025-03-04 | 780.71K shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2024-03-31 | 288.17K shares 10-Q · filed 2024-05-08 | 288.17K shares derived: sum of 2 quarters · filed 2025-03-04 | 668.59K shares derived: sum of 3 quarters · filed 2025-03-04 | 862.87K shares derived: sum of 4 quarters · filed 2025-03-04 |
| 2023-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-04 | 380.42K shares derived: sum of 2 quarters · filed 2025-03-04 | 574.70K shares derived: sum of 3 quarters · filed 2025-03-04 | 695.23K shares 10-K · filed 2025-03-04 |
| 2023-09-30 | 380.42K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-06 | 574.70K shares derived: sum of 2 quarters · filed 2023-11-06 | 695.23K shares 10-Q · filed 2023-11-06 | 695.23K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-06-30 | 194.28K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | 314.80K shares 10-Q · filed 2023-08-08 | 314.80K shares derived: sum of 3 quarters · filed 2024-03-05 | 314.80K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2023-03-31 | 120.52K shares 10-Q · filed 2023-05-04 | 120.52K shares derived: sum of 2 quarters · filed 2024-03-05 | 120.52K shares derived: sum of 3 quarters · filed 2024-03-05 | 230.04K shares derived: sum of 4 quarters · filed 2024-03-05 |
| 2022-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-05 | 0.00 shares derived: sum of 2 quarters · filed 2024-03-05 | 109.52K shares derived: sum of 3 quarters · filed 2024-03-05 | 690.22K shares 10-K · filed 2024-03-05 |
| 2022-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-08 | 109.52K shares derived: sum of 2 quarters · filed 2022-11-08 | 690.22K shares 10-Q · filed 2022-11-08 | 702.05K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-06-30 | 109.52K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | 690.22K shares 10-Q · filed 2022-08-11 | 702.05K shares derived: sum of 3 quarters · filed 2023-03-02 | 712.82K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2022-03-31 | 580.70K shares 10-Q · filed 2022-05-12 | 592.54K shares derived: sum of 2 quarters · filed 2023-03-02 | 603.30K shares derived: sum of 3 quarters · filed 2023-03-02 | 981.32K shares derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-12-31 | 11.84K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | 22.61K shares derived: sum of 2 quarters · filed 2023-03-02 | 400.62K shares derived: sum of 3 quarters · filed 2023-03-02 | 588.98K shares 10-K · filed 2023-03-02 |
| 2021-09-30 | 10.77K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-10 | 388.78K shares derived: sum of 2 quarters · filed 2021-11-10 | 577.14K shares 10-Q · filed 2021-11-10 | |
| 2021-06-30 | 378.01K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-12 | 566.38K shares 10-Q · filed 2021-08-12 | ||
| 2021-03-31 | 188.36K shares 10-Q · filed 2021-06-03 | |||
| 2020-12-31 | 2.95M shares 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |